IHS Chemical Week

Chemical Week Magazine :: Newsbriefs

Bayer bids to acquire Norwegian pharma company

6:04 AM MST | December 6, 2013

The board of Algeta (Oslo) says it has received a preliminary acquisition proposal from Bayer. Bayer has offered to pay 336 Norwegian kroner ($54.68) per Algeta share, valuing the bid at $2.4 billion. Discussions are at an early stage, and further announcements may come, Algeta says. Bayer and Algeta are partners in Xofigo, which was approved by FDA in May for the treatment of castration-resistant prostate cancer, symptomatic bone metastases, and no known visceral metastatic disease. Xofigo is the first alpha particle–emitting radioactive therapeutic agent...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa